AI assistant
Sending…
US BANCORP \DE\ — Director's Dealing 2022
Dec 14, 2022
29924_dirs_2022-12-14_969a4644-80ba-4112-b81b-d7b62a364d70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: US BANCORP \DE\ (USB)
CIK: 0000036104
Period of Report: 2022-12-12
Reporting Person: CECERE ANDREW (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-12 | Common Stock, $0.01 par value | M | 84948.0000 | $33.9900 | Acquired | 1041690.0000 | Direct |
| 2022-12-12 | Common Stock, $0.01 par value | S | 84948.0000 | $43.5080 | Disposed | 956742.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-12 | Employee Stock Option (Right to Buy) | $33.9900 | M | 84948.0000 | Disposed | 2023-02-14 | Common Stock, $0.01 par value (84948.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 13025.0000 | Indirect |
| Common Stock, $0.01 par value | 341.0000 | Indirect |
Footnotes
F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $43.50 to $43.525. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: Based on a plan report dated November 30, 2022, the most recent plan report available.
F3: The options vested in four equal annual installments beginning on February 14, 2014.
More from US BANCORP \DE\
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 15